Skip to main content
. 2020 May 2;12(5):1146. doi: 10.3390/cancers12051146

Figure 1.

Figure 1

Schematic diagram of the study design. (A) Among various cancer-related hallmarks and pathways, cell cycle process (CCP) was identified as the dominant risk factor for cancer-specific survival (CSS) in bladder cancer (BCa) patients. (B) Combined methods were used to establish a robust CCP-related gene signature for CSS. (C) The prognostic value of the gene signature was further validated in different cohorts. (D) Clinical application.